REFERENCES
- Keiser P, Nassar N, White C, Koen G, Moreno S. Compari-son of nevirapine- and efavirenz-containing antiretroviral regimens in antiretroviral-naive patients: a cohort study. HIV Clin Trials. 2002 ;3(4):296–303.
- Phillips AN, et al. Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients. AIDS. 2001:15:2385–2395.
- Matthews GV, et al. Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study. AIDS. 2002:16:53–61.
- Cozzi-Lepri A, et al. Virologic and immunologic response to regimens containing nevirapine or efavirenz in combination with 2 nucleoside analogues in the Italian Cohort Naive Anti retrovirals (lcoNA) Study. J Infect Dis. 2002 ;185:1062–1069.
- van Leth F, et al. Results of the 2NN Study: a randomized comparative trial of first-line antiretroviral therapy with regi-mens containing either nevirapine alone, efavirenz alone or both drugs combined, together with stavudine and lamivudine. Paper presented at: 10th CR01; 2003.
- Van Leeowen R. Design of 2NN: a large scale, randomized comparison of efavirenz and nevirapine. Presented at: 6th ICDTHIV; 2002; Glasgow. Poster 34.
- Phillips AN, et al. Use of observational databases to evalu-ate the effectiveness of antiretroviral therapy for HIV infec-tion: comparison of cohort studies with randomized trials. EuroSIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups. AIDS. 1999:13:2075–2082.
- Pocock SJ and Elbourne DR. Randomized trials or obser-vational tribulations. N Engl J Med. 2000;342:1907–1909.